217 related articles for article (PubMed ID: 19469021)
1. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.
Gao H; Lu Q; Liu X; Cong H; Zhao L; Wang H; Lin D
Cancer Sci; 2009 Apr; 100(4):782-5. PubMed ID: 19469021
[TBL] [Abstract][Full Text] [Related]
2. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.
Wang B; Chen D; Chen Y; Hu Z; Cao M; Xie Q; Chen Y; Xu J; Zheng S; Li L
J Proteome Res; 2012 Feb; 11(2):1217-27. PubMed ID: 22200553
[TBL] [Abstract][Full Text] [Related]
3. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
4. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
[TBL] [Abstract][Full Text] [Related]
5. ¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis.
Qi SW; Tu ZG; Peng WJ; Wang LX; Ou-Yang X; Cai AJ; Dai Y
World J Gastroenterol; 2012 Jan; 18(3):285-90. PubMed ID: 22294833
[TBL] [Abstract][Full Text] [Related]
6. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
Nahon P; Amathieu R; Triba MN; Bouchemal N; Nault JC; Ziol M; Seror O; Dhonneur G; Trinchet JC; Beaugrand M; Le Moyec L
Clin Cancer Res; 2012 Dec; 18(24):6714-22. PubMed ID: 23136190
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
[TBL] [Abstract][Full Text] [Related]
9. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
10. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.
Yang Y; Li C; Nie X; Feng X; Chen W; Yue Y; Tang H; Deng F
J Proteome Res; 2007 Jul; 6(7):2605-14. PubMed ID: 17564425
[TBL] [Abstract][Full Text] [Related]
11. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
Pasha HF; Mohamed RH; Radwan MI
Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.
Thumanu K; Sangrajrang S; Khuhaprema T; Kalalak A; Tanthanuch W; Pongpiachan S; Heraud P
J Biophotonics; 2014 Apr; 7(3-4):222-31. PubMed ID: 24639420
[TBL] [Abstract][Full Text] [Related]
15. Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma.
Lu Y; Li N; Gao L; Xu YJ; Huang C; Yu K; Ling Q; Cheng Q; Chen S; Zhu M; Fang J; Chen M; Ong CN
Cancer Res; 2016 May; 76(10):2912-20. PubMed ID: 26976432
[TBL] [Abstract][Full Text] [Related]
16. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
17. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
18. A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.
Assi N; Fages A; Vineis P; Chadeau-Hyam M; Stepien M; Duarte-Salles T; Byrnes G; Boumaza H; Knüppel S; Kühn T; Palli D; Bamia C; Boshuizen H; Bonet C; Overvad K; Johansson M; Travis R; Gunter MJ; Lund E; Dossus L; Elena-Herrmann B; Riboli E; Jenab M; Viallon V; Ferrari P
Mutagenesis; 2015 Nov; 30(6):743-53. PubMed ID: 26130468
[TBL] [Abstract][Full Text] [Related]
19. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
[TBL] [Abstract][Full Text] [Related]
20. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
